Recommended usage and dosage of pirfenidone
Pirfenidone, a pyridone compound, is a drug specially designed to treat fibrotic diseases, especially in the treatment of idiopathic pulmonary fibrosis (IPF). It provides new treatment hope for patients by effectively inhibiting excessive proliferation of fibroblasts, reducing abnormal collagen synthesis, and exhibiting significant anti-inflammatory and antioxidant effects. In addition to IPF, pirfenidone has shown its therapeutic potential in other fibrotic diseases, such as renal interstitial fibrosis and liver fibrosis.

As for the usage and dosage of pirfenidone, patients should strictly follow the doctor's instructions. When treatingIPF, a strategy of gradually increasing the dose is often used. In the initial stage, it is recommended to take 200mg each time, three times a day. Over the next two weeks, the dose will be gradually increased by 200 mg each time until reaching a maintenance dose of 600 mg each time, so that the total daily dose is 1800 mg. However, it is worth noting that the specific maintenance dose should be adjusted based on the patient's actual condition and drug tolerance. It is usually recommended to keep the maintenance dose above 1200 mg per day.
Currently, domestically produced pirfenidone has been launched in China and has been included in Category B of medical insurance, allowing more patients to benefit from this innovative drug. The packaging specification is 200mg × 63 tablets, and the out-of-pocket cost after medical insurance reimbursement is about 1,500 yuan. Additionally, for patients looking for a more affordable option, generic versions of pirfenidone available in the Indian market may be a good option. Especially the version produced by the Indian company Cipla, each package contains 200 mg × 150 tablets and the price is only about 650 yuan.
But no matter which version you choose, patients should follow their doctor's specific recommendations and adjust the dosage and usage of the drug based on their actual situation. At the same time, in order to ensure the effectiveness and safety of treatment, patients should receive regular examinations and evaluations from doctors while taking pirfenidone.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)